86 related articles for article (PubMed ID: 1684572)
1. The molecular targets of T cells in acquired immunity to tuberculosis.
Orme IM
Immunol Lett; 1991 Oct; 30(2):207-11. PubMed ID: 1684572
[No Abstract] [Full Text] [Related]
2. Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection.
Orme IM; Roberts AD; Griffin JP; Abrams JS
J Immunol; 1993 Jul; 151(1):518-25. PubMed ID: 8100846
[TBL] [Abstract][Full Text] [Related]
3. Human cellular immune responses to Mycobacterium tuberculosis.
Barnes PF; Modlin RL
Curr Top Microbiol Immunol; 1996; 215():197-219. PubMed ID: 8791715
[No Abstract] [Full Text] [Related]
4. Regulatory T-cell subsets in response to specific Mycobacterium tuberculosis antigens in vitro distinguish among individuals with different QTF and TST reactivity.
Serrano CJ; Castañeda-Delgado JE; Trujillo-Ochoa JL; González-Amaro R; García-Hernández MH; Enciso-Moreno JA
Clin Immunol; 2015 Apr; 157(2):145-55. PubMed ID: 25728490
[TBL] [Abstract][Full Text] [Related]
5. Transient role of CD4+CD25+ regulatory T cells in mycobacterial infection in mice.
Ozeki Y; Sugawara I; Udagawa T; Aoki T; Osada-Oka M; Tateishi Y; Hisaeda H; Nishiuchi Y; Harada N; Kobayashi K; Matsumoto S
Int Immunol; 2010 Mar; 22(3):179-89. PubMed ID: 20139174
[TBL] [Abstract][Full Text] [Related]
6. The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non-protective Th1 immune response in mice.
Palma C; Iona E; Giannoni F; Pardini M; Brunori L; Orefici G; Fattorini L; Cassone A
Cell Microbiol; 2007 Jun; 9(6):1455-65. PubMed ID: 17250590
[TBL] [Abstract][Full Text] [Related]
7. Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activity.
Joosten SA; van Meijgaarden KE; van Weeren PC; Kazi F; Geluk A; Savage ND; Drijfhout JW; Flower DR; Hanekom WA; Klein MR; Ottenhoff TH
PLoS Pathog; 2010 Feb; 6(2):e1000782. PubMed ID: 20195504
[TBL] [Abstract][Full Text] [Related]
8. Human CD4 T-Cells With a Naive Phenotype Produce Multiple Cytokines During
Orlando V; La Manna MP; Goletti D; Palmieri F; Lo Presti E; Joosten SA; La Mendola C; Buccheri S; Ottenhoff THM; Dieli F; Caccamo N
Front Immunol; 2018; 9():1119. PubMed ID: 29875774
[TBL] [Abstract][Full Text] [Related]
9. Difference in TB10.4 T-cell epitope recognition following immunization with recombinant TB10.4, BCG or infection with Mycobacterium tuberculosis.
Billeskov R; Grandal MV; Poulsen C; Christensen JP; Winther N; Vingsbo-Lundberg C; Hoang TT; van Deurs B; Song YH; Aagaard C; Andersen P; Dietrich J
Eur J Immunol; 2010 May; 40(5):1342-54. PubMed ID: 20186878
[TBL] [Abstract][Full Text] [Related]
10. Analysis of T cells recruited during delayed-type hypersensitivity to purified protein derivative (PPD) versus challenge with tuberculosis infection.
Pais TF; Silva RA; Smedegaard B; Appelberg R; Andersen P
Immunology; 1998 Sep; 95(1):69-75. PubMed ID: 9767459
[TBL] [Abstract][Full Text] [Related]
11. Association of mycobacterial antigen-specific CD4(+) memory T cell subsets with outcome of pulmonary tuberculosis.
Wang X; Cao Z; Jiang J; Niu H; Dong M; Tong A; Cheng X
J Infect; 2010 Feb; 60(2):133-9. PubMed ID: 19878691
[TBL] [Abstract][Full Text] [Related]
12. Persistence and turnover of antigen-specific CD4 T cells during chronic tuberculosis infection in the mouse.
Winslow GM; Roberts AD; Blackman MA; Woodland DL
J Immunol; 2003 Feb; 170(4):2046-52. PubMed ID: 12574375
[TBL] [Abstract][Full Text] [Related]
13. In vitro expansion of CD4+CD25highFOXP3+CD127low/- regulatory T cells from peripheral blood lymphocytes of healthy Mycobacterium tuberculosis-infected humans.
Hougardy JM; Verscheure V; Locht C; Mascart F
Microbes Infect; 2007 Sep; 9(11):1325-32. PubMed ID: 17890131
[TBL] [Abstract][Full Text] [Related]
14. Influence of diabetes mellitus on immunity to human tuberculosis.
Kumar Nathella P; Babu S
Immunology; 2017 Sep; 152(1):13-24. PubMed ID: 28543817
[TBL] [Abstract][Full Text] [Related]
15. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
[TBL] [Abstract][Full Text] [Related]
16. [Immunological protection against Mycobacterium tuberculosis infection].
Yoshikai Y
Tanpakushitsu Kakusan Koso; 2009 Jun; 54(8 Suppl):1014-9. PubMed ID: 21089533
[No Abstract] [Full Text] [Related]
17. Impact of antiretroviral and tuberculosis therapies on CD4
Chiacchio T; Petruccioli E; Vanini V; Cuzzi G; La Manna MP; Orlando V; Pinnetti C; Sampaolesi A; Antinori A; Caccamo N; Goletti D
Immunol Lett; 2018 Jun; 198():33-43. PubMed ID: 29635002
[TBL] [Abstract][Full Text] [Related]
18. Mycobacterial lipopeptides elicit CD4+ CTLs in Mycobacterium tuberculosis-infected humans.
Bastian M; Braun T; Bruns H; Röllinghoff M; Stenger S
J Immunol; 2008 Mar; 180(5):3436-46. PubMed ID: 18292570
[TBL] [Abstract][Full Text] [Related]
19. ESAT-6- and CFP-10-specific Th1, Th22 and Th17 cells in tuberculous pleurisy may contribute to the local immune response against Mycobacterium tuberculosis infection.
Qiao D; Yang BY; Li L; Ma JJ; Zhang XL; Lao SH; Wu CY
Scand J Immunol; 2011 Apr; 73(4):330-7. PubMed ID: 21223348
[TBL] [Abstract][Full Text] [Related]
20. Active tuberculosis is characterized by an antigen specific and strictly localized expansion of effector T cells at the site of infection.
Nemeth J; Rumetshofer R; Winkler HM; Burghuber OC; Müller C; Winkler S
Eur J Immunol; 2012 Nov; 42(11):2844-50. PubMed ID: 22821397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
